A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Wolfgang H.W. Schuette; Andreas Gröschel; Martin Sebastian; Stefan Andreas; Thomas Müller; Folker Schneller; Sylvia Guetz; Corinna Eschbach; Sabine Bohnet; Monika I. Leschinger; Martin Reck

doi:10.1016/j.cllc.2012.10.001

A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2012.10.001 ◽

2013 ◽

Vol 14 (3) ◽

pp. 215-223 ◽

Cited By ~ 28

Author(s):

Wolfgang H.W. Schuette ◽

Andreas Gröschel ◽

Martin Sebastian ◽

Stefan Andreas ◽

Thomas Müller ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer

Investigational New Drugs ◽

10.1007/s10637-011-9631-7 ◽

2011 ◽

Vol 30 (3) ◽

pp. 1144-1149 ◽

Cited By ~ 14

Author(s):

Xin Zhao ◽

Kai Mei ◽

Xiaohong Cai ◽

Jing Chen ◽

Jingrui Yu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Recombinant Human Endostatin ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

Preliminary results of a multicenter randomized phase II trial of two different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7124 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7124-7124 ◽

Cited By ~ 1

Author(s):

M. Rinaldi ◽

S. Novello ◽

I. Bernardini ◽

L. Crinò ◽

M. Nardi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdm474 ◽

2008 ◽

Vol 19 (2) ◽

pp. 362-369 ◽

Cited By ~ 195

Author(s):

R. Rosell ◽

G. Robinet ◽

A. Szczesna ◽

R. Ramlau ◽

M. Constenla ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2301-z ◽

2013 ◽

Vol 72 (5) ◽

pp. 1103-1110 ◽

Cited By ~ 6

Author(s):

Luis E. Raez ◽

Edgardo S. Santos ◽

R. Timothy Webb ◽

James Wade ◽

Roger A. Brito ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy

Download Full-text

A randomized phase II study of gemcitabine (G) and carboplatin (C) with or without cediranib (AZD2171 [CED]) as first-line therapy in advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7603 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7603-7603 ◽

Cited By ~ 6

Author(s):

G. K. Dy ◽

S. J. Mandrekar ◽

G. D. Nelson ◽

H. J. Ross ◽

R. H. Ansari ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

P-463 Preliminary results of a multicenter randomized phase II trial oftwo different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)80956-0 ◽

2005 ◽

Vol 49 ◽

pp. S238

Author(s):

I. Bernardini ◽

M. Rinaldi ◽

L. Crinò ◽

M. Nardi ◽

F. De Marinis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

P2-291: Results of a multicenter randomized phase II trial of two different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283999.81017.30 ◽

2007 ◽

Vol 2 (8) ◽

pp. S687-S688

Author(s):

Silvia Novello ◽

Carmelo Tibaldi ◽

Giorgio V. Scagliotti ◽

Lucio Crinó ◽

Mario Nardi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non–Small-cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2016.12.003 ◽

2017 ◽

Vol 18 (3) ◽

pp. 340-343 ◽

Cited By ~ 9

Author(s):

Kun-lin Li ◽

Li Li ◽

Peng Zhang ◽

Jun Kang ◽

Yu-bo Wang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Faculty Opinions recommendation of Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1100156.556314 ◽

2008 ◽

Author(s):

Nico van Zandwijk

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.07.013 ◽

2017 ◽

Vol 12 (2) ◽

pp. 383-389 ◽

Cited By ~ 9

Author(s):

Silvia Novello ◽

Giorgio Scagliotti ◽

Gilberto de Castro ◽

Murat Kiyik ◽

Rubén Kowalyszyn ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Open Label ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text